IRAK inhibitor can improve insulin sensitivity in insulin-resistant mice fed with a high-fat diet.

IRAKis can increase insulin sensitivity and their efficacy is comparable to pioglitazone. However, combined administration of pioglitazone and IRAKi had no synergistic effect compared with monotherapy.